oxotremorine has been researched along with Catatonia in 5 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
Catatonia: A neuropsychiatric disorder characterized by one or more of the following essential features: immobility, mutism, negativism (active or passive refusal to follow commands), mannerisms, stereotypies, posturing, grimacing, excitement, echolalia, echopraxia, muscular rigidity, and stupor; sometimes punctuated by sudden violent outbursts, panic, or hallucinations. This condition may be associated with psychiatric illnesses (e.g., SCHIZOPHRENIA; MOOD DISORDERS) or organic disorders (NEUROLEPTIC MALIGNANT SYNDROME; ENCEPHALITIS, etc.). (From DSM-IV, 4th ed, 1994; APA, Thesaurus of Psychological Index Terms, 1994)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
David, J | 1 |
Kaul, CL | 1 |
Grewal, RS | 1 |
Lisciani, R | 1 |
Baldini, A | 1 |
de Feo, G | 1 |
Silvestrini, B | 1 |
Brossi, A | 1 |
Pool, W | 1 |
Sheppard, H | 1 |
Burns, JJ | 1 |
Kaiser, A | 1 |
Bigler, R | 1 |
Bartholini, G | 1 |
Pletscher, A | 1 |
Horst, WD | 1 |
Pool, WR | 1 |
Spiegel, HE | 1 |
Mori, J | 1 |
Sato, Y | 1 |
Oashi, T | 1 |
Hitomi, M | 1 |
5 other studies available for oxotremorine and Catatonia
Article | Year |
---|---|
Pharmacological & biochemical characterization of antiparkinson drugs in reserpinized mice.
Topics: Animals; Antiparkinson Agents; Ataxia; Blepharoptosis; Catatonia; Disease Models, Animal; Humans; Ma | 1979 |
Pharmacological investigations on etoperidone, a new psychotropic agent.
Topics: Analgesics; Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Body Temperature; Catato | 1978 |
L-DOPA: chemical modifications and biological evaluation.
Topics: Animals; Antiparkinson Agents; Blepharoptosis; Catatonia; Disease Models, Animal; Humans; Hypothermi | 1974 |
Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Blepharoptosis; Brain; | 1973 |
[Pharmacological study of amantadine, a new antiparkinson drug].
Topics: Amantadine; Amines; Animals; Antiparkinson Agents; Avoidance Learning; Brain; Catatonia; Dopamine; D | 1974 |